Comparative studies of different gliadin preparations in detecting antigliadin antibodies.
Antigliadin antibodies (AGA) have been used as indicators of celiac disease. The presence of these antibodies in other gastrointestinal and liver disorders and even in normal healthy controls casts a shadow on the diagnostic significance of AGA. We examined 91 normal controls of varying ages and 97 patients with various gastrointestinal and liver disorders. Forty-eight of 97 nonceliac patients were positive for AGA, and diagnosis-specific incidences ranged as high as 75% in patients with small bowel disease. In addition, the levels of AGA were dependent upon age as their presence increased from 12% in children with a mean age of 10, to 35-40% in normals within the 60-70 age group. The lack of celiac disease specificity of AGA was not due to either the source of gliadin nor to the sensitivities of the test methods. Both the enzyme-linked immunosorbent assay (ELISA) and the immunofluorescence methods gave comparable results. ELISA was more sensitive than immunofluorescence. These results thus strongly suggest that AGA are not markers of celiac disease and increase with age in normals.
D000328:Adult; D000368:Aged; D000906:Antibodies / Q000032:analysis*; D002648:Child; D004797:Enzyme-Linked Immunosorbent Assay; D005455:Fluorescent Antibody Technique; D005767:Gastrointestinal Diseases / Q000276:immunology; D005903:Gliadin / Q000276:immunology* / Q000302:isolation & purification; D006801:Humans; D008107:Liver Diseases / Q000276:immunology; D008875:Middle Aged; D010940:Plant Proteins / Q000276:immunology*
D000906:Antibodies; D010940:Plant Proteins; D005903:Gliadin